Rankings
▼
Calendar
TLPH Q4 2019 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena
TLPH
Talphera, Inc.
$18M
Q4 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$475,000
-22.5% YoY
Gross Profit
-$2M
-464.4% margin
Operating Income
-$15M
-3156.2% margin
Net Income
-$14M
-3036.4% margin
EPS (Diluted)
$-3.63
QoQ Revenue Growth
-21.9%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$91M
Total Liabilities
$133M
Stockholders' Equity
-$41M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$475,000
$613,000
-22.5%
Gross Profit
-$2M
-$3M
+33.7%
Operating Income
-$15M
-$11M
-36.6%
Net Income
-$14M
-$13M
-14.9%
← FY 2019
All Quarters
Q1 2020 →